[Updated 9/16/16, 12:24 pm. See below.] The Boston area has already generated more tech IPOs this year than it did in all of 2015. That’s not saying much. Burlington, MA-based Everbridge today became the second Massachusetts tech company to go public in 2016, following networking technology firm Acacia Communications (NASDAQ: [[ticker:ACIA]]). Last year, only one … Continue reading “Everbridge Bags $90M in Boston Area’s Second Tech IPO of 2016”
Category: Boston
How to Teach Computational Thinking
Computational thinking is going to be a defining feature of the future—and it’s an incredibly important thing to be teaching to kids today. There’s always lots of discussion (and concern) about how to teach traditional mathematical thinking to kids. But looking to the future, this pales in comparison to the importance of teaching computational thinking. … Continue reading “How to Teach Computational Thinking”
Greiner Shifts to CyPhy Works CTO, Former Kiva Exec Takes Helm
In a leadership change at a high-profile drone startup in the Boston area, CyPhy Works founder Helen Greiner has stepped aside as CEO and moved into the role of chief technology officer. The startup’s new CEO is Lance Vanden Brook, a former executive with warehouse robotics firm Kiva Systems, now owned by Amazon (NASDAQ: [[ticker:AMZN]]). … Continue reading “Greiner Shifts to CyPhy Works CTO, Former Kiva Exec Takes Helm”
BitSight Nabs $40M as Cybersecurity Ratings Sector Picks Up Steam
BitSight Technologies wasn’t looking to raise more money from investors when GGV Capital came calling in April. The cybersecurity ratings startup still had nearly $20 million stashed in the bank from the Series B funding round it raised in June 2015, says Tom Turner, BitSight’s chief operating officer and president. But BitSight executives decided they … Continue reading “BitSight Nabs $40M as Cybersecurity Ratings Sector Picks Up Steam”
Tekuma Receives New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=40b3f3ee-56d4-4905-ad6b-43f24d4f1204 Date 9/15/2016 Company Name Tekuma Mailing Address 85 Hancock Street Cambridge, MA 02139 USA Company Description Tekuma is an on-demand one-stop art curation and distribution service. We activates spaces into galleries by bringing art and design to your walls. Website http://www.tekuma.io Transaction Type Venture Equity Transaction Amount Undisclosed Transaction Round Undisclosed … Continue reading “Tekuma Receives New Funding”
Relay Therapeutics Garners $57,000,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1aff652b-09a9-4027-9fc6-5e765d2e40cd Date 9/15/2016 Company Name Relay Therapeutics Mailing Address 215 First Street 3rd Floor Cambridge, MA 02142 USA Company Description Relay Therapeutics is committed to discovering and developing medicines that will make a transformative difference for patients by building the first dedicated drug discovery pipeline centered on protein motion. Website http://www.relaytx.com Transaction … Continue reading “Relay Therapeutics Garners $57,000,000 Series A Funding Round”
Applause Lands $35,000,000 Series F Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cb5434c2-ed5a-4138-a0dd-eaaf76733bf5 Date 9/15/2016 Company Name Applause Mailing Address 100 Pennsylvania Avenue Southborough, MA 01701 USA Company Description Applause equips you with software testing tools & services you need to launch web, mobile & wearable apps that win. Website http://www.applause.com Transaction Type Venture Equity Transaction Amount $35,000,000 Transaction Round Series F Proceeds Purposes … Continue reading “Applause Lands $35,000,000 Series F Funding Round”
Aerie Shares Rocket As Glaucoma Drug Hits Mark in Phase 3
For people dealing with the creeping blindness of glaucoma, the most effective treatments are eye drops called prostaglandin analogues, or PGAs. They’re not a cure, but taken chronically, they’re the best way to slow the progression of the disease, which is why they’ve been the standard of care for glaucoma for more than two decades. … Continue reading “Aerie Shares Rocket As Glaucoma Drug Hits Mark in Phase 3”
Boston Healthtech Lab Links Startups with Hospitals, Bose, & Others
Pulse@MassChallenge, the new Boston “lab” for healthcare technology startups, revealed more details Wednesday about its strategy and how the program fits into a broader initiative attempting to make Massachusetts the world’s digital health hub. The lab is run by MassChallenge, the Boston-based nonprofit that operates startup accelerator programs around the world. The lab’s inaugural session … Continue reading “Boston Healthtech Lab Links Startups with Hospitals, Bose, & Others”
Biotech Week Boston
From the event organizer: Biotech Week Boston is the destination where passionate scientists and innovators converge to partner and share ground breaking data, research and ideas. Join 3000+ global life science professionals at this year’s meeting, held October 4-7, 2016 in Boston. Get your $199 exhibit hall pass with VIP code XCON199 at www.BiotechWeekBoston.com.
Sofinnova, Atlas Put $35M Into Delinia to Tackle Autoimmune Diseases
Autoimmune diseases occur when our immune systems mistakenly start fighting parts of our own bodies, rather than foreign invaders. The trick is to stop the attack without weakening our body’s defenses. That’s the idea behind a new startup that launched this morning called Delinia. The company, with operations in Cambridge, MA, and San Francisco, CA, … Continue reading “Sofinnova, Atlas Put $35M Into Delinia to Tackle Autoimmune Diseases”
C4 Therapeutics Promotes CSO Phillips to President, CEO Resigns
Cambridge, MA-based C4 Therapeutics has named chief scientific officer Andrew Phillips its president. Phillips is taking over for former president and CEO Jason Fisherman, who has resigned to pursue other opportunities.
Accenture-Backed Applause Takes $35M Bow, Expands App Testing Service
Software is at the heart of most interactions between companies and their customers these days, from mobile apps to e-commerce, and beyond. And that has spawned a big industry around the testing of digital products. The latest sign is a fresh $35 million investment in Applause, the Framingham, MA-based provider of digital testing services for … Continue reading “Accenture-Backed Applause Takes $35M Bow, Expands App Testing Service”
New Relay Therapeutics Aims Supercomputers, $57M At Protein Motion
Nearly ten years ago, academics at Stanford University trying to divine how proteins fold into their complicated shapes—an action that can take a millionth to a thousandth of a second—began recruiting people at home to volunteer their computers in the off hours. Back then, crowdsourced computing muscle was necessary to probe the mystery of a … Continue reading “New Relay Therapeutics Aims Supercomputers, $57M At Protein Motion”
Crop Enhancement Obtains $8,500,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a9d2cb2f-59ac-45e4-b4cc-168ec8a80792 Date 9/14/2016 Company Name Crop Enhancement Mailing Address 35 Spinelli Place Cambridge, MA 02138 USA Company Description Founded in 2011 by David Soane, Ph.D., a serial entrepreneur and inventor in the field of materials science and surface chemistry, Crop Enhancement is commercializing an innovative set of environmentally friendly chemistry formulations that … Continue reading “Crop Enhancement Obtains $8,500,000 Series B Funding”
From Art Collecting to Allego: Meet the Busiest CEO in Boston Tech
Yuchun Lee has a plan, or a thesis, for everything. The tech entrepreneur is perhaps best known for leading Unica, a marketing software company that went public and was bought by IBM for $480 million in 2010. He was also a member of the famed MIT blackjack team in the ‘90s, and is still barred … Continue reading “From Art Collecting to Allego: Meet the Busiest CEO in Boston Tech”
Moderna Names UMass Biochemist Melissa Moore New CSO
Cambridge, MA-based Moderna Therapeutics has named University of Massachusetts Medical School biochemistry professor Melissa Moore as its new chief scientific officer. Moore, who is already on Moderna’s scientific advisory board, will start her new role on Oct. 3. She’ll remain a part-time faculty member at UMass Medical School.
Agtech Startup Crop Enhancement Reaps $8.5M for Plant Coating Tech
Pesticides are a challenging agricultural problem, because rain washes them off of plants and the resulting runoff can poison other plants, animals, and water systems. Agricultural biotech startup Crop Enhancement is testing a plant protection product that could reduce pesticide use and perhaps do away with these chemical treatments altogether. Today, the company is announcing … Continue reading “Agtech Startup Crop Enhancement Reaps $8.5M for Plant Coating Tech”
Octiv Snags Backing from GE Ventures, Plans to Continue Expansion
Octiv, the Indianapolis-based startup working on productivity tools for sales teams, announced last week that it has secured investment capital from GE Ventures, which has offices in Boston, San Francisco, and other cities across the country. The amount contributed by GE Ventures, the venture capital arm of General Electric (NYSE: [[ticker:GE]]), was undisclosed. The funding … Continue reading “Octiv Snags Backing from GE Ventures, Plans to Continue Expansion”
Avitide Receives Series D Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=56a50a60-ee82-48f7-b8da-952e38f0d922 Date 9/13/2016 Company Name Avitide Mailing Address 16 Cavendish Court Lebanon, NH 03766 USA Company Description Avitide develops customized biopharmaceutical affinity purification products with an industry-leading discovery and development service time Website http://www.avitide.com Transaction Type Venture Equity Transaction Amount Undisclosed Transaction Round Series D Proceeds Purposes Proceeds from this financing will … Continue reading “Avitide Receives Series D Round”
3 Startups to Watch From MIT’s Delta V Accelerator
Anyone who thinks they can look at a dozen startups and accurately pick out the one or two that will become successful businesses is kidding themselves. But it’s still fun to try. On Friday, MIT lifted the curtain on 14 student-led teams that worked throughout the summer building technology startups aimed at solving problems in … Continue reading “3 Startups to Watch From MIT’s Delta V Accelerator”
Sanofi, Verily Fund Diabetes Startup With $500M
[Updated, 9/12/16, 2:35 p.m. See below.] French healthcare giant Sanofi (NYSE: [[ticker:SNY]]) and Verily, the life-science group within Google’s parent company Alphabet (NASDAQ: [[ticker:GOOG]]), are each putting nearly $250 million into a new startup, Onduo, that will develop diabetes treatments. Onduo will be based in Cambridge, MA, and run by a former big-box superstore executive, … Continue reading “Sanofi, Verily Fund Diabetes Startup With $500M”
RaNA Taps Shire Exec As New CSO
Cambridge, MA-based RaNA Therapeutics has named Thomas McCauley its chief scientific officer. McCauley comes to RaNA after a six-year stint at Shire Pharmaceuticals, where he most recently served as the company’s head of nonclinical development.
Grab the Early Bird Rate for What’s Hot in Boston Healthtech
Leaders across the medical, digital health, and biotechnology industries are coming together for this special event on November 17 at the Broad Institute in Cambridge, MA. Join us for interactive panels, keynote talks, and presentations from an elite group of leaders discussing how technology is changing the healthcare industry. Check out our confirmed speakers—and keep … Continue reading “Grab the Early Bird Rate for What’s Hot in Boston Healthtech”
How We Won $50,000 in SBA Growth Accelerator Fund Contest
Recently, the student accelerator program mystartupXX, a joint program of UC San Diego’s Rady School of Management and the Jacobs School of Engineering, won a $50,000 grant from the U.S. Small Business Administration as a Growth Accelerator Fund Competition winner. We were one of 68 winners announced Aug. 31 in the nationwide contest. This was … Continue reading “How We Won $50,000 in SBA Growth Accelerator Fund Contest”
Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push
Investors hoping to buy into the vast, yet still unproven drugmaking potential of the gene editing system CRISPR-Cas9 will soon have three different companies to choose from. CRISPR Therapeutics filed for an IPO on Friday, meaning it could soon join Boston-area rivals Editas Medicine and Intellia Therapeutics in the expanding club of publicly traded CRISPR-Cas9 … Continue reading “Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push”
MIT’s Bhatia Refocuses Spotlight on Gender Diversity in Biotech
Sangeeta Bhatia has been talking about the woeful lack of diversity in the life sciences and other high-tech industries since the late 1980s, when she was an undergraduate studying biomedical engineering at Brown University. She thinks the situation is improving, but not nearly fast enough. “I think the statistics are all getting better. What I … Continue reading “MIT’s Bhatia Refocuses Spotlight on Gender Diversity in Biotech”
Altiostar Secures $2,500,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9165813b-c1b3-4d86-8b5f-2900869c552e Date 9/12/2016 Company Name Altiostar Mailing Address 200 Ames Pond Drive Tewksbury, MA 01876 USA Company Description Altiostar is the mobile broadband industry’s first provider of Virtual RAN (vRAN) with Ethernet front haul, for software-intensive LTE eNodeB. Our unique solution is designed to improve quality of experience, enhance spectral efficiency and … Continue reading “Altiostar Secures $2,500,000 New Financing”
Business Leaders Convene for What’s Hot in Boston Healthtech on Nov. 17
Boston has something special going on in terms of health-related technologies and applications: world-renowned medical facilities, training institutions, academic researchers, health IT companies, startups, and investors. Yet the future of healthtech—and Boston’s place in it—is uncertain. As things like health analytics, genomics, telemedicine, and wearables become more integrated into hospitals and home life, new opportunities … Continue reading “Business Leaders Convene for What’s Hot in Boston Healthtech on Nov. 17”
Bio Roundup: Cancer Wishes and Shopping Lists, Allergan Pricing & More
[Corrected, 9/12/16, 4:28 p.m. See below.] What do cancer experts want? The moon, perhaps. As part of the Obama administration’s “cancer moonshot” program, a panel of scientists this week presented a set of broad, ambitious recommendations to speed up the pace of cancer research, treatment, and prevention. The scientific goals, writ large, included nationwide data … Continue reading “Bio Roundup: Cancer Wishes and Shopping Lists, Allergan Pricing & More”
Tyler Jacks, Cancer Moonshot Panel Co-Chair, Discusses Roadmap
The Obama administration wants to speed up cancer research with its “Cancer Moonshot” program—packing 10 years’ worth of work on prevention and treatment programs into five is one of its rallying cries. Agreeing on what to do, and how to do it, is the first step. The FDA agreed this summer to reorganize the way … Continue reading “Tyler Jacks, Cancer Moonshot Panel Co-Chair, Discusses Roadmap”
SessionM Obtains $35,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f416bca0-fe7d-4446-a638-7803acd2151b Date 9/9/2016 Company Name SessionM Mailing Address 2 Seaport Lane 11th Floor Boston, MA 02210 USA Company Description SessionM is the next generation consumer loyalty and engagement platform. The company’s cloud-based solutions integrate loyalty marketing technology with ad serving and data management capabilities to drive personalized consumer relationships through the mobile … Continue reading “SessionM Obtains $35,000,000 New Round”
Connected2Fiber Obtains $11,200,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4d534795-c66e-418f-87f1-aca5e4b3c054 Date 9/9/2016 Company Name Connected2Fiber Mailing Address 105b South Street Hopkinton, MA 01748 USA Company Description Connected2Fiber is a SaaS platform for market participation in the network industry helping network owners and network buyers improve transparency, speed and effectiveness with information, automation and predictive algorithms. Website http://www.connected2fiber.com Transaction Type Venture Equity … Continue reading “Connected2Fiber Obtains $11,200,000 New Round”
AnTolRx Secures $4,000,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=06b84639-49e9-43f4-94ab-d8c369e0e924 Date 9/9/2016 Company Name AnTolRx Mailing Address Building 1400 West Cambridge, MA 02139 USA Company Description At AnTolRx we are approaching the treatment of autoimmune diseases differently–through the development of novel nanoparticle-based therapies to promote antigen-specific immune tolerance. Standard therapies broadly suppress the immune system, inducing side effects that may include … Continue reading “AnTolRx Secures $4,000,000 Series A Funding Round”
Agrivida Garners $20,390,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=47f83e04-527b-4bb5-b174-edba345e9447 Date 9/9/2016 Company Name Agrivida Mailing Address 200 Boston Avenue Cambridge, MA 02155 USA Company Description Agrivida is an agricultural biotechnology company that creates renewable, biomass-based alternative fuels and raw materials. Website http://www.agrivida.com Transaction Type Venture Equity Transaction Amount $20,390,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. 7 … Continue reading “Agrivida Garners $20,390,000 New Funding”
SessionM Snags $35M From General Atlantic, Salesforce, & Others
It’s a busy week for mobile tech in the Boston area. After text-messaging app firm HeyWire was sold to Salesforce, now comes mobile-marketing startup SessionM announcing it has received a $35 million investment. The “strategic growth” round was led by General Atlantic. New investor Salesforce Ventures also contributed, along with previous backers Causeway Media Partners, … Continue reading “SessionM Snags $35M From General Atlantic, Salesforce, & Others”
Salesforce Buys HeyWire to Help Businesses Reach Customers Via SMS
Salesforce has made another Boston-area acquisition, scooping up HeyWire in a deal that underscores the growing importance of mobile messaging among the ways that businesses communicate with customers. The deal’s terms weren’t disclosed, but it’s surely much smaller than the $2.8 billion that San Francisco-based Salesforce (NYSE: [[ticker:CRM]]) paid earlier this year for Burlington, MA-based … Continue reading “Salesforce Buys HeyWire to Help Businesses Reach Customers Via SMS”
The Power of Polymers
Throughout history, innovative humans have developed technology to overcome or adapt to challenges in the natural world. As it turns out, some of our most important advances were actually inspired by a naturally occurring group of materials: polymers. Derived from Greek words meaning “many parts,” the word polymer refers to a large molecule composed of … Continue reading “The Power of Polymers”
Boston Tech Watch: GE, PillPack, Tech IPOs, Lola, Amazon, & More
[Updated 9/8/16, 4:46 pm. See below.] This week in Boston tech, we’re tracking the prospects for the state’s second tech IPO of the year, GE’s investments in 3D printing, new investments in pharmacy technology, software talent on the move, and more. Read on for details. —Online pharmacy and medication-management firm PillPack has raised $31.1 million … Continue reading “Boston Tech Watch: GE, PillPack, Tech IPOs, Lola, Amazon, & More”
FRX Polymers Garners $22,648,054 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3d77ace9-a37a-4756-8c2c-5d35adab114b Date 9/8/2016 Company Name FRX Polymers Mailing Address 200 Turnpike Road Chelmsford, MA 01824 USA Company Description FRX Polymers manufactures Nofia polyphosphonates, a brand of novel non-halogen, transparent, high melt flowing, fire resistant plastics. Website http://www.frxpolymers.com Transaction Type Venture Equity Transaction Amount $22,648,054 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were … Continue reading “FRX Polymers Garners $22,648,054 New Financing”
scPharmaceuticals Garners $8,183,797 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9ac3ef78-a577-4929-ba2f-9d1b1e594c6a Date 9/8/2016 Company Name scPharmaceuticals Mailing Address 131 Hartwell Avenue Lexington, MA 02421 USA Company Description scPharmaceticals is creating innovative and important new therapeutic options by administering drugs subcutaneously using a convenient two component delivery system suitable for patient self-administration. Website http://www.scpharma.com Transaction Type Venture Equity Transaction Amount $8,183,797 Transaction Round … Continue reading “scPharmaceuticals Garners $8,183,797 New Round”
Proclara Biosciences Garners $47,000,000 Series E Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d21df4e0-3905-4f4d-a848-ca96be9c8ba6 Date 9/8/2016 Company Name Proclara Biosciences Mailing Address 222 3rd St. Cambridge, MA 02142 USA Company Description Proclara Biosciences is a biotechnology company advancing product candidates developed based on proprietary GAIM technology, which is capable of simultaneously targeting multiple toxic misfolded proteins. Website http://www.proclarabio.com Transaction Type Venture Equity Transaction Amount $47,000,000 … Continue reading “Proclara Biosciences Garners $47,000,000 Series E Financing”
PillPack Receives $31,100,023 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d62d2c8a-ad2c-412b-9d5a-eec318b5cd7e Date 9/8/2016 Company Name PillPack Mailing Address 250 Commercial St. Manchester, NH 03101 USA Company Description PillPack is pharmacy simplified. We fill, sort, and deliver all your medications in personalized packets based on when you need to take them. Our service helps you take the right meds at the right time, … Continue reading “PillPack Receives $31,100,023 New Financing Round”
Solace Therapeutics Secures $13,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2155eca3-1a1a-4506-b2af-fff25c3fe0c2 Date 9/8/2016 Company Name Solace Therapeutics Mailing Address 135 Newbury Street Framingham, MA 01701 USA Company Description Solace Therapeutics is developing a non-surgical device specifically for the treatment of Stress Urinary Incontinence (SUI). Website http://www.solacetx.com Transaction Type Venture Equity Transaction Amount $13,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not … Continue reading “Solace Therapeutics Secures $13,000,000 New Financing”
Pfizer Taps Harvard Professor to Lead Neuro R&D Unit
Pfizer has named Ole Isacson, a neurology professor at Harvard Medical School, the chief scientific officer and senior vice president of its neuroscience research division. Isacson, who has done more than two decades of work in Parkinson’s and other neurodegenerative diseases, will report to Pfizer R&D chief Mikael Dolsten at the pharma giant’s research hub in … Continue reading “Pfizer Taps Harvard Professor to Lead Neuro R&D Unit”
Celgene Plots Speedy FDA Filing for Agios Blood Cancer Drug
It typically takes about 14 years to discover a cancer drug, develop it, and get it to market. Agios Pharmaceuticals has a chance to beat that timeline. Cambridge, MA-based Agios (NASDAQ: [[ticker:AGIO]]) said in a regulatory filing this morning that its partner Celgene (NASDAQ: [[ticker:CELG]]), of Summit, NJ, expects to file for FDA approval of a … Continue reading “Celgene Plots Speedy FDA Filing for Agios Blood Cancer Drug”
With Government Backing, Moderna Joins the Zika Vaccine Chase
Moderna Therapeutics, whose unusual and still unproven drug-producing technology has attracted more than a billion dollars in funding and partnerships, is joining the scramble to produce a vaccine to protect against Zika virus infection. The virus, which has gone from a biological afterthought to a global health crisis in a few years, can cause microcephaly, … Continue reading “With Government Backing, Moderna Joins the Zika Vaccine Chase”
New Cybersecurity Alliance Continues Trend of Industry Collaboration
For the cybersecurity industry, 2016 is shaping up to be the year of alliances. There have been a series of tie-ups, as security-tech companies try to boost their businesses and amplify their products via acquisitions. IBM bought Resilient Systems, Cisco Systems snapped up CloudLock, Symantec acquired Blue Coat, and Carbon Black purchased Confer, to name … Continue reading “New Cybersecurity Alliance Continues Trend of Industry Collaboration”
With New Name and $47M, Proclara Begins First Big Alzheimer’s Test
Despite a litany of high profile failures among drugs to fight Alzheimer’s disease, biotechs and pharma companies continue to pour billions of dollars into the fight. The latest firm to get a financial boost is a startup from Cambridge, MA, that until today has been known as Neurophage Pharmaceuticals. The company has raised $47 million … Continue reading “With New Name and $47M, Proclara Begins First Big Alzheimer’s Test”
Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches
Thanks to remarkable results in a small group of patients, including former U.S. President Jimmy Carter, cancer immunotherapy has spurred talk of once impossible-to-imagine cures and has gained its share, perhaps more than its share, of hype. But immunotherapy is also creating new challenges and exacerbating old ones for doctors, patients, and researchers. These new … Continue reading “Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches”